Walmart to alter opioid prescription policies at its pharmacies

Date: 2018-05-08   Author: Shikha Sinha  Category: #news

Walmart to alter opioid prescription policies at its pharmacies

In a bid to curb opioid misuse and abuse, Walmart Inc., has announced that it will only fill first-time opioid prescriptions for acute pain to seven days or even less across the United States. Reportedly, the initiative will be commenced within 60 days and comes on the heels of the rising number of healthcare entities tightening the rules surrounding the filing of opioid prescriptions.

Sources reveal that pharmacies, beginning 1st January 2020, will be restricting the dosage of opioids to not more than 50 MMEs (morphine milligrams equivalent) per day and will require online prescriptions for controlled substances. The e-prescriptions are deemed to minimize error and prevent prescription frauds.  

Marybeth Hays, Walmart’s executive VP of health and wellness and consumables, was quoted stating that the company is taking action in the fight against the nation’s opioid epidemic. In an effort to continue to be a part of the solution, Walmart is introducing new programs, tools and policies that will be aimed at addressing the critical issues faced by the patients & communities.

Reliable reports claim that the initiatives will also be applicable to Sam’s Club Pharmacies, which is owned by Walmart. Several other companies have also been making similar efforts to help mitigate the opioid epidemic.

As per industry analysts, these proposals have disclosed that limitations are important to lower the number of painkillers that are available to be unlawfully diverted, stem overprescribing, and lower the potential for addiction.

Opioid overdose crisis and the proposal for its limits have garnered significant support from several shareholders, owing to which a bill in the Senate will be restricting the initial prescriptions for acute pain to 3 days.

Meanwhile, the AMA (American Medical Association) has countered that the limits over opioid dosage & supply are arbitrary and believes that the decision needs to be left between the physician and the patient.



About Author


Shikha Sinha linkdin-boxtwitter

Shikha Sinha

Shikha currently manages the content team at AlgosOnline. An electrical & electronics engineer by education, she has prior experience in content & technology writing, content marketing, market research, and business development domains. Her other interests inc...

Read More

Post Recommendents

3D Visualization System Market Professional Survey 2021 by Manufacturers, Share, Growth, Trends, Types and Applications, Forecast to 2027

Author: Ashwin Naphade

The and United States 3D Visualization System Market Forecast Report provides details analysis of and United States 3D Visualization System industry which will accelerate your business. and United States 3D Visualization System market report cover...


3D Systems Market Share, By Product Analysis, Application, End-Use, Regional Outlook, Competitive Strategies & Forecast up to 2027

Author: Ashwin Naphade

and China 3D Systems Market Trends covers the companies’ data including Growth potential analysis, Industry segmentation, Business trends, Growth drivers, Price trend analysis. The Report also Gives Detail Analysis on Market concern Like an...


Cinema Ticketing System Service Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2027

Author: Ashwin Naphade

and United States Cinema Ticketing System Service Market report provides key statistics on the market status of the and United States Cinema Ticketing System Service Industry and is a valuable source of guidance and direction for companies and in...